Etiology of sporadic Alzheimer's disease: Somatostatin, neprilysin, and amyloid β peptide

Medical Hypotheses

Volumn 65, Issue 3, 2005, Pages 498-500

  Hama, E ^a   Saido, T C ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; PRESENILIN 1; SOMATOSTATIN;

AGING; ALZHEIMER DISEASE; APE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN LEVEL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; HEALTH HAZARD; HUMAN; HYPOTHESIS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RODENT; SENILE DEMENTIA;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; NEPRILYSIN; PEPTIDE FRAGMENTS; RISK FACTORS; SOMATOSTATIN;

MAMMALIA; RODENTIA;

EID: 21844431659     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.02.045     Document Type: Article

References (18)

1. J. Golomb, A. Kluger, and S.H. Ferris Mild cognitive impairment: identifying and treating the earliest stages of Alzheimer's disease Neurosci News 3 4 2000 46 53
2. K. Duff, C. Eckman, and C. Zehr Increased amyloid-β 42 (43) in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713
3. C.A. Lemere, F. Lopera, and K.S. Kosik The E280A Presenilin 1 mutation leads to a distinct Alzheimer's disease phenotype: increased Aβ42 deposition and severe cerebellar pathology Nat Med 2 1996 1146 1150
4. 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat Med 6 2000 143 150
5. N. Iwata, S. Tsubuki, and Y. Takaki Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
6. N. Iwata, Y. Takaki, and S. Fukami Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging J Neurosci Res 70 2002 493 500
7. K. Yasojima, H. Akiyama, and E.G. McGeer Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide Neurosci Lett 297 2001 97 100
8. S. Tsubuki, Y. Takaki, and T.C. Saido Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation Lancet 361 2003 1957 1958
9. 42 through modulation of proteolytic degradation Nat Med 4 2005 434 439
10. M. Hayashi, A. Yamashita, and K. Shimizu Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNA during aging Brain Res 749 1997 283 289
11. T. Lu, Y. Pan, and S.Y. Kao Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
12. P. Davies, R. Katzman, and R.D. Terry Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia Nature 288 1980 279 280
13. D.-S. Wang, N. Iwata, E. Hama, T.C. Saido, and D.W. Dickson Oxidized neprilysin in aging and Alzheimer's disease brains Biochem Biophys Res Commun 310 2003 236 241
14. E. Storey, and R. Capprai The amyloid precursor protein of Alzheimer's disease and the Aβ peptide Neuropathol Appl Neurobiol 25 1999 81 97
15. K. Yasojima, E.G. McGeer, and P.L. McGeer Relationship between β amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain Brain Res 919 2001 115 121
16. R. Li, K. Lindholm, and L.B. Yang Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients Proc Natl Acad Sci USA 101 2004 3632 3637
17. H. Funato, M. Yoshimura, and K. Kusui Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease Am J Pathol 152 1998 1633 1640
18. L.N. Moller, C.E. Stidsen, B. Hartmann, and J.J. Holst Somatostatin receptors Biochim Biophys Acta 1616 2003 1 84